U.S. Markets closed

Investors Should Be Worried About Pfizer's Reversal

barrons.com
Investors Should Be Worried About Pfizer's Reversal

President Donald Trump has effectively inserted himself into the executive suite of a major pharmaceuticals company. After a presidential tweet Monday that criticized its decision to raise some drug prices, Pfizer (ticker: PFE) said it would postpone the increases. Late Tuesday, Pfizer tweeted that “